148 related articles for article (PubMed ID: 20106648)
1. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection.
Renom F; Yáñez A; Garau M; Rubí M; Centeno MJ; Gorriz MT; Medinas M; Ramis F; Soriano JB; Alvar Agustí
Respir Med; 2010 Jun; 104(6):840-8. PubMed ID: 20106648
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
[TBL] [Abstract][Full Text] [Related]
3. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
[TBL] [Abstract][Full Text] [Related]
4. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.
Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G
Respiration; 2007; 74(1):19-25. PubMed ID: 16675894
[TBL] [Abstract][Full Text] [Related]
5. Prediction of risk of COPD exacerbations by the BODE index.
Marin JM; Carrizo SJ; Casanova C; Martinez-Camblor P; Soriano JB; Agusti AG; Celli BR
Respir Med; 2009 Mar; 103(3):373-8. PubMed ID: 19013781
[TBL] [Abstract][Full Text] [Related]
6. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.
Tsimogianni AM; Papiris SA; Kanavaki S; Stathopoulos GT; Sotiropoulou C; Manali ED; Michalopoulou P; Roussos C; Kotanidou A
Respirology; 2009 Nov; 14(8):1114-20. PubMed ID: 19761538
[TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].
Wavre-Oberhänsli A; Nicod LP
Rev Med Suisse; 2010 Nov; 6(272):2240-3. PubMed ID: 21207736
[TBL] [Abstract][Full Text] [Related]
8. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
9. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
[TBL] [Abstract][Full Text] [Related]
10. Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.
Allegra L; Blasi F; Diano P; Cosentini R; Tarsia P; Confalonieri M; Dimakou K; Valenti V
Respir Med; 2005 Jun; 99(6):742-7. PubMed ID: 15878491
[TBL] [Abstract][Full Text] [Related]
11. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
12. A prediction model for bacterial etiology in acute exacerbations of COPD.
Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
[TBL] [Abstract][Full Text] [Related]
13. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
Alamoudi OS
Respirology; 2007 Mar; 12(2):283-7. PubMed ID: 17298464
[TBL] [Abstract][Full Text] [Related]
14. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.
Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A
Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
Murphy TF
Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
[TBL] [Abstract][Full Text] [Related]
16. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Soler-Cataluña JJ; Martínez-García MA; Román Sánchez P; Salcedo E; Navarro M; Ochando R
Thorax; 2005 Nov; 60(11):925-31. PubMed ID: 16055622
[TBL] [Abstract][Full Text] [Related]
17. Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.
Boixeda R; Almagro P; Díez-Manglano J; Cabrera FJ; Recio J; Martin-Garrido I; Soriano JB
Int J Chron Obstruct Pulmon Dis; 2015; 10():2581-91. PubMed ID: 26664106
[TBL] [Abstract][Full Text] [Related]
18. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study.
Garcia-Vidal C; Almagro P; Romaní V; Rodríguez-Carballeira M; Cuchi E; Canales L; Blasco D; Heredia JL; Garau J
Eur Respir J; 2009 Nov; 34(5):1072-8. PubMed ID: 19386694
[TBL] [Abstract][Full Text] [Related]
20. Cough and sputum production as risk factors for poor outcomes in patients with COPD.
Miravitlles M
Respir Med; 2011 Aug; 105(8):1118-28. PubMed ID: 21353517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
